<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">


LSX World Congress formerly known as Biotech and Money Congress
etc.venues St Paul's
February 5-6, 2019
 

 

Why showcase?

 

Inv€$table Showcase opportunities exist for all stages of private and public companies to present news and deal flow or pitch an audience of active investors and pharma. These 15mins showcases allow companies to deliver succinct, hard hitting and insightful presentations to an audience seeking to uncover innovative research and / or technology.
 
Assigned to either a Biotech, Medtech/Healthtech or Deeptech themed room, presenting company executives will present to a live audience, plus have their showcases video recorded and turned into a post-event IR piece. An enhanced option to have the presentations webcast is also available.
 
If you are looking to announce news / deal flow or actively looking to raise capital or profile with life science and tech investors, pharma and medtech commercial leaders, then a showcase is your best opportunity to get noticed at the LSX World Congress.
  • Biotech Showcase opportunities exist for, but not exclusively: Drug Discovery, Pre-Clinical, Clinical and OTM Therapeutics companies. 
  • Medtech/Healthtech Showcase opportunities exist for, but not exclusively: Medtech, Device, Digital Health and Diagnostic companies.
  • Deeptech Showcase opportunities exist for, but not exclusively: AI, Big Data, Blockchain, Predictive Analytics and Machine Learning companies.
To secure one, enquire below.

 

Meet our showcasing companies

Anima Biotech

Anima Biotech

Anima Biotech is pioneering Translation Control Therapeutics, a new class of drugs that control protein translation. Our novel platform enables for the first time to visualize and specifically control the synthesis of...

READ MORE
BioCubaFarma

BioCubaFarma

BioCubaFarma is an efficient and competitive business organization that researches, develops, produces and markets medicines, diagnostic systems, medical equipment and high technology services, base

READ MORE
Bluebee

Bluebee

BlueBee is a leading provider of high-performance genomics solutions, enabling genomic labs to substantially reduce cost and turn-around time. The BlueBee genomics platform supports cross-functional teams of...

READ MORE
Bridge Biotec

Bridge Biotec

Bridge is an ambitious company aiming to be revenue generating within 18 months by taking the lead project to exit, via out-licencing or trade sale, by investing in the innovative programs to treat serious inflammator

READ MORE
drfocused

Drfocused

We started drfocused to reclaim the tens of thousands of hours of medical time that are wasted each year through form-filling, administration, and extra paperwork.

Our team brings...

READ MORE
Immatics

Immatics

Immatics is a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting immunotherapies for the treatment of cancer.

Our transfo

READ MORE
Immunicum

Immunicum

Immunicum is establishing a unique immuno-oncology approach through the development of allogeneic, off-the-shelf cell-based therapies. Our goal is to improve survival outcomes and quality of life by.. READ MORE

ISA Pharmaceuticals

ISA Pharmaceuticals

ISA Pharmaceuticals is a privately held company based in the Netherlands. It focuses on the development of rationally designed, fully synthetic immunotherapeutics for the treatment of cancer and persistent viral infect..

READ MORE
Lytix Biopharma

Lytix Biopharma

 Lytix Biopharma is a clinical stage pharmaceutical company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. The Comp

READ MORE
Mitotech

Mitotech

Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Our ..

READ MORE
Proteon Pharmaceuticals

Proteon Pharmaceuticals

PROTEON uses bacteriophages as the foundation for preventing and eradicating infectious diseases in animals, humans and plants.

Bacteriophages are naturally occurring... READ MORE

Storm Therapeutics

Storm Therapeutics

STORM Therapeutics is a University of Cambridge spin-out, translating the groundbreaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in...

READ MORE
ENQUIRE HERE

Never miss an update

Sign up to event updates to hear about new speakers, promotions, conference news and networking events.